索宝蛋白 - Financials

索宝蛋白 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019
+Revenue	1.6B	1.7B	1.8B	1.6B	1.3B	1.1B
Revenue Growth %	-11.0%	-5.4%	16.5%	24.0%	20.3%	--
Total Revenue	1.6B	1.7B	1.8B	1.6B	1.3B	1.1B
Cost Of Revenue	1.4B	1.5B	1.6B	1.4B	1.1B	891.0M
+Gross Profit	186.0M	237.0M	245.0M	222.0M	185.0M	172.0M
Gross Margin %	12.0%	13.6%	13.3%	14.0%	14.5%	16.2%
Total Operating Cost	1.4B	1.6B	1.7B	1.4B	1.2B	986.0M
Selling Expenses	22.9M	19.9M	19.1M	19.1M	16.2M	40.2M
Admin Expenses	38.9M	35.5M	28.1M	27.2M	33.0M	32.4M
Rd Expenses	10.4M	10.4M	12.2M	12.4M	11.1M	7.9M
Finance Expenses	-12.7M	181,300	-7.2M	5.7M	8.6M	6.4M
+Operating Income	148.0M	180.0M	189.0M	147.0M	120.0M	81.6M
Operating Margin %	9.5%	10.3%	10.2%	9.3%	9.4%	7.7%
Non Operating Income	356,700	223,600	541,300	565,200	245,100	360,800
Non Operating Expenses	4.6M	7.6M	1.0M	4.6M	524,000	788,900
Investment Income	5.3M	21,500	-454,900	277,300	6.6M	611,500
Fair Value Change Income	6.2M	--	--	-527,900	1.4M	-96,300
Asset Disposal Income	-29,700	353,400	542,700	--	68,500	85,200
Asset Impairment Loss	4.1M	734,600	3.8M	5.8M	8.9M	1.1M
Other Income	16.2M	17.0M	8.2M	4.7M	10.5M	3.7M
Income Before Tax	144.0M	172.0M	189.0M	143.0M	120.0M	81.1M
Income Tax	22.9M	26.3M	20.8M	18.6M	21.8M	15.1M
+Net Income	121.0M	146.0M	168.0M	124.0M	97.7M	66.0M
Net Margin %	7.8%	8.4%	9.1%	7.8%	7.6%	6.2%
Net Income Attributable	121.0M	146.0M	168.0M	124.0M	97.7M	66.0M
Eps Basic	0.63	1.02	1.17	0.86	0.68	0.57
Eps Diluted	0.63	1.02	1.17	0.86	0.68	0.57

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019
Cash And Equivalents	320.0M	1.1B	88.0M	123.0M	70.3M	23.1M
Trading Financial Assets	500.0M	--	820,700	--	60.5M	89.0M
Accounts Receivable	149.0M	175.0M	151.0M	121.0M	91.8M	127.0M
Notes Receivable	15.8M	6.5M	5.6M	2.0M	2.2M	6.7M
Notes And Accounts Receivable	164.0M	181.0M	156.0M	123.0M	94.0M	133.0M
Prepayments	13.1M	8.9M	7.4M	24.3M	13.1M	7.2M
Inventory	279.0M	215.0M	244.0M	189.0M	131.0M	151.0M
Total Current Assets	1.3B	1.5B	515.0M	476.0M	391.0M	413.0M
Long Term Equity Investment	13.7M	14.5M	14.9M	11.6M	2.9M	2.0M
Fixed Assets	--	606.0M	526.0M	365.0M	294.0M	312.0M
Fixed Assets Total	612.0M	606.0M	526.0M	365.0M	295.0M	312.0M
Construction In Progress	--	10.3M	36.5M	64.1M	25.2M	3.0M
Construction In Progress Total	92.6M	10.3M	36.5M	64.1M	25.2M	3.0M
Intangible Assets	61.7M	59.4M	45.5M	47.0M	33.5M	22.6M
Long Term Deferred Expenses	--	--	--	--	--	48,600
Total Non Current Assets	788.0M	697.0M	630.0M	499.0M	363.0M	345.0M
Total Assets	2.1B	2.2B	1.1B	975.0M	753.0M	759.0M
Short Term Borrowings	23.8M	83.8M	85.1M	103.0M	20.0M	39.1M
Accounts Payable	120.0M	108.0M	194.0M	142.0M	60.2M	63.8M
Advance Receipts	--	327,700	--	--	--	10.9M
Contract Liabilities	5.6M	6.1M	8.2M	8.5M	10.9M	--
Total Current Liabilities	191.0M	235.0M	324.0M	286.0M	119.0M	202.0M
Total Non Current Liabilities	19.4M	16.8M	18.5M	605,300	110,900	83,900
Total Liabilities	210.0M	252.0M	342.0M	287.0M	119.0M	203.0M
Paid In Capital	191.0M	191.0M	144.0M	144.0M	144.0M	144.0M
Capital Reserve	1.2B	1.3B	338.0M	334.0M	332.0M	323.0M
Surplus Reserve	43.4M	37.1M	26.5M	21.6M	13.4M	5.3M
Retained Earnings	402.0M	383.0M	295.0M	189.0M	145.0M	84.1M
Equity Attributable	1.9B	1.9B	803.0M	688.0M	634.0M	556.0M
Total Equity	1.9B	1.9B	803.0M	688.0M	634.0M	556.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019
Cash From Sales	1.7B	1.8B	2.0B	1.6B	1.4B	1.1B
Tax Refunds Received	64.1M	59.4M	68.7M	48.7M	31.1M	21.4M
Total Operating Cash Inflow	1.8B	1.9B	2.1B	1.7B	1.4B	1.1B
Cash Paid For Goods	1.5B	1.6B	1.7B	1.4B	1.1B	921.0M
Cash Paid To Employees	104.0M	94.2M	90.3M	82.8M	69.2M	69.5M
Taxes Paid	36.7M	36.9M	39.1M	23.9M	30.4M	34.9M
Total Operating Cash Outflow	1.6B	1.7B	1.9B	1.5B	1.2B	1.1B
Operating Cash Flow	148.0M	144.0M	186.0M	162.0M	198.0M	44.3M
Total Investing Cash Inflow	1.5B	217.0M	180.0M	208.0M	1.1B	362.0M
Total Investing Cash Outflow	2.2B	312.0M	324.0M	320.0M	1.1B	488.0M
Investing Cash Flow	-656.0M	-95.4M	-144.0M	-112.0M	-41.5M	-126.0M
Cash From Borrowings	23.8M	93.8M	115.0M	103.0M	20.0M	49.2M
Dividends And Interest Paid	95.9M	45.7M	63.1M	74.1M	29.8M	36.7M
Debt Repayments	83.8M	95.0M	133.0M	20.0M	39.0M	58.2M
Total Financing Cash Inflow	23.8M	1.1B	115.0M	103.0M	20.0M	209.0M
Total Financing Cash Outflow	273.0M	159.0M	197.0M	94.9M	130.0M	152.0M
Financing Cash Flow	-249.0M	937.0M	-82.0M	8.1M	-110.0M	57.7M
Net Change In Cash	-753.0M	985.0M	-34.9M	57.3M	42.7M	-24.1M
Ending Cash Balance	320.0M	1.1B	88.0M	123.0M	65.7M	23.0M
Capex	169.0M	99.7M	144.0M	161.0M	72.5M	38.4M